Literature DB >> 22612622

Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions.

Lucas Schirmer1, Doron Merkler, Fatima B König, Wolfgang Brück, Christine Stadelmann.   

Abstract

The extent of irreversible neuroaxonal damage is the key determinant of permanent disability in traumatic and inflammatory conditions of the central nervous system (CNS). Structural damage is nevertheless in part compensated by neuroplastic events. However, it is unknown whether the same kinetics and mechanisms of neuroaxonal de- and regeneration take place in inflammatory and traumatic conditions. We analyzed neuroaxonal degeneration and plasticity in early multiple sclerosis (MS) lesions and traumatic brain injury (TBI). Neuroaxonal degeneration identified by the presence of SMI31+ chromatolytic neurons and SMI32+ axonal profiles were characteristic features of leukocortical TBI lesions. Axonal transport disturbances as determined by amyloid precursor protein (APP)+ spheroids were present in both TBI and MS lesions to a similar degree. Neurons expressing growth-associated protein 43 (GAP43) and synaptophysin (Syn) were found under both pathological conditions. However, axonal swellings immunopositive for GAP43 and Syn clearly prevailed in subcortical MS lesions, suggesting a higher regenerative potential in MS. In this context, GAP43+/APP+ axonal spheroid ratios correlated with macrophage infiltration in TBI and MS lesions, supporting the idea that phagocyte activation might promote neuroplastic events. Furthermore, axonal GAP43+ and Syn+ swellings correlated with prolonged survival after TBI, indicating a sustained regenerative response.
© 2012 The Authors; Brain Pathology © 2012 International Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22612622     DOI: 10.1111/j.1750-3639.2012.00608.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  20 in total

1.  A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis.

Authors:  Xiao-Lu Yuan; Yi-Peng Zhao; Jie Huang; Jun-Chen Liu; Wen-Qian Mao; Jun Yin; Bi-Wen Peng; Wan-Hong Liu; Song Han; Xiao-Hua He
Journal:  CNS Neurosci Ther       Date:  2018-03-25       Impact factor: 5.243

2.  Short-term cuprizone feeding verifies N-acetylaspartate quantification as a marker of neurodegeneration.

Authors:  Barbara Maria Krauspe; Wolfgang Dreher; Cordian Beyer; Werner Baumgartner; Bernd Denecke; Katharina Janssen; Claus-Dieter Langhans; Tim Clarner; Markus Kipp
Journal:  J Mol Neurosci       Date:  2014-09-05       Impact factor: 3.444

3.  A novel and robust conditioning lesion induced by ethidium bromide.

Authors:  Edmund R Hollis; Nao Ishiko; Kristine Tolentino; Ernest Doherty; Maria J Rodriguez; Nigel A Calcutt; Yimin Zou
Journal:  Exp Neurol       Date:  2014-12-23       Impact factor: 5.330

Review 4.  Thalamus pathology in multiple sclerosis: from biology to clinical application.

Authors:  Markus Kipp; Nina Wagenknecht; Cordian Beyer; Sebastian Samer; Jens Wuerfel; Omid Nikoubashman
Journal:  Cell Mol Life Sci       Date:  2014-11-23       Impact factor: 9.261

Review 5.  Role of TREM2 in the Development of Neurodegenerative Diseases After Traumatic Brain Injury.

Authors:  Chunhao Zhang; Shiwen Chen
Journal:  Mol Neurobiol       Date:  2022-10-20       Impact factor: 5.682

6.  Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis.

Authors:  Francesco Mori; Robert Nisticò; Georgia Mandolesi; Sonia Piccinin; Dalila Mango; Hajime Kusayanagi; Nicola Berretta; Alessandra Bergami; Antonietta Gentile; Alessandra Musella; Carolina G Nicoletti; Ferdinando Nicoletti; Fabio Buttari; Nicola B Mercuri; Gianvito Martino; Roberto Furlan; Diego Centonze
Journal:  Neuromolecular Med       Date:  2013-07-28       Impact factor: 3.843

7.  Analysis of CD4+ CD8+ double-positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions.

Authors:  A Waschbisch; L Sammet; S Schröder; D-H Lee; A Barrantes-Freer; C Stadelmann; R A Linker
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

8.  Dietary fructose aggravates the pathobiology of traumatic brain injury by influencing energy homeostasis and plasticity.

Authors:  Rahul Agrawal; Emily Noble; Laurent Vergnes; Zhe Ying; Karen Reue; Fernando Gomez-Pinilla
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-01       Impact factor: 6.200

9.  Microglial process convergence on axonal segments in health and disease.

Authors:  Savannah D Benusa; Audrey D Lafrenaye
Journal:  Neuroimmunol Neuroinflamm       Date:  2020-03-21

10.  Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice.

Authors:  Michael P Nelson; Tonia E Tse; Darrel B O'Quinn; Stefanie M Percival; Edgar A Jaimes; David G Warnock; John J Shacka
Journal:  Acta Neuropathol Commun       Date:  2014-02-14       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.